» Articles » PMID: 34744736

Metabolic Activation of the Toxic Natural Products From Herbal and Dietary Supplements Leading to Toxicities

Overview
Journal Front Pharmacol
Date 2021 Nov 8
PMID 34744736
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Currently, herbal and dietary supplements have been widely applied to prevent and treat various diseases. However, the potential toxicities and adverse reactions of herbal and dietary supplements have been increasingly reported, and have gradually attracted widespread attention from clinical pharmacists and physicians. Metabolic activation of specific natural products from herbal and dietary supplements is mediated by hepatic cytochrome P450 or intestinal bacteria, and generates chemical reactive/toxic metabolites that bind to cellular reduced glutathione or macromolecules, and form reactive metabolites-glutathione/protein/DNA adducts, and these protein/DNA adducts can result in toxicities. The present review focuses on the relation between metabolic activation and toxicities of natural products, and provides updated, comprehensive and critical comment on the toxic mechanisms of reactive metabolites. The key inductive role of metabolic activation in toxicity is highlighted, and frequently toxic functional groups of toxic natural products were summarized. The biotransformation of drug cytochrome P450 or intestinal bacteria involved in metabolic activation were clarified, the reactive metabolites-protein adducts were selected as biomarkers for predicting toxicity. And finally, further perspectives between metabolic activation and toxicities of natural products from herbal and dietary supplements are discussed, to provide a reference for the reasonable and safe usage of herbal and dietary supplements.

Citing Articles

Anti-tumor effect and hepatotoxicity mechanisms of psoralen.

Meng D, Dong Y, Shang Q, Sun Z Front Pharmacol. 2024; 15:1442700.

PMID: 39161897 PMC: 11331265. DOI: 10.3389/fphar.2024.1442700.


Natural products for Gut-X axis: pharmacology, toxicology and microbiology in mycotoxin-caused diseases.

Li K, Wang S, Qu W, Ahmed A, Enneb W, Obeidat M Front Pharmacol. 2024; 15:1419844.

PMID: 38978980 PMC: 11228701. DOI: 10.3389/fphar.2024.1419844.


Mercury Levels in Selected Medicines and Dietary Supplements in Poland.

Brodziak-Dopierala B, Fischer A, Ahnert B Biol Trace Elem Res. 2024; 203(3):1685-1700.

PMID: 38935258 PMC: 11872768. DOI: 10.1007/s12011-024-04269-3.


The Role of Natural Products in Diabetic Retinopathy.

Zhao Y, Chen Y, Yan N Biomedicines. 2024; 12(6).

PMID: 38927345 PMC: 11200400. DOI: 10.3390/biomedicines12061138.


Predicting phase-I metabolism of piceatannol: an in silico study.

Rajan R, Engels M, Ramanathan M In Silico Pharmacol. 2024; 12(1):52.

PMID: 38854674 PMC: 11153392. DOI: 10.1007/s40203-024-00228-x.


References
1.
Jiang J, Yang B, Ji L, Yang L, Mao Y, Hu Z . Metabolic-induced cytotoxicity of diosbulbin B in CYP3A4-expressing cells. Toxicol In Vitro. 2016; 38:59-66. DOI: 10.1016/j.tiv.2016.11.006. View

2.
Poor M, Zrinyi Z, Koszegi T . Structure related effects of flavonoid aglycones on cell cycle progression of HepG2 cells: Metabolic activation of fisetin and quercetin by catechol-O-methyltransferase (COMT). Biomed Pharmacother. 2016; 83:998-1005. DOI: 10.1016/j.biopha.2016.08.009. View

3.
He Y, Lian W, Ding L, Fan X, Ma J, Zhang Q . Lung injury induced by pyrrolizidine alkaloids depends on metabolism by hepatic cytochrome P450s and blood transport of reactive metabolites. Arch Toxicol. 2020; 95(1):103-116. PMC: 8765307. DOI: 10.1007/s00204-020-02921-0. View

4.
Nencini C, Galluzzi P, Pippi F, Menchiari A, Micheli L . Hepatotoxicity of Teucrium chamaedrys L. decoction: role of difference in the harvesting area and preparation method. Indian J Pharmacol. 2014; 46(2):181-4. PMC: 3987187. DOI: 10.4103/0253-7613.129313. View

5.
Lekehal M, Pessayre D, Lereau J, Moulis C, Fouraste I, Fau D . Hepatotoxicity of the herbal medicine germander: metabolic activation of its furano diterpenoids by cytochrome P450 3A Depletes cytoskeleton-associated protein thiols and forms plasma membrane blebs in rat hepatocytes. Hepatology. 1996; 24(1):212-8. DOI: 10.1002/hep.510240134. View